Since the excessive production of VEGF suppresses immunity, combination therapy with ICIs and VEGFIs has been used in hepatocellular carcinoma and other types of cancer to enhance the individual anti-tumor effect of ICIs and VEGFIs (Fukumura et al., 2018). This evidence concerns the gene VEGFA and hepatocellular carcinoma.